Literature DB >> 25325948

Chromatographic molecular weight measurements for heparin, its fragments and fractions, and other glycosaminoglycans.

Barbara Mulloy1, John Hogwood.   

Abstract

Glycosaminoglycan samples are usually polydisperse, consisting of molecules with differing length and differing sequence. Methods for measuring the molecular weight of heparin have been developed to assure the quality and consistency of heparin products for medicinal use, and these methods can be applied in other laboratory contexts. In the method described here, high-performance gel permeation chromatography is calibrated using appropriate heparin molecular weight markers or a single broad standard calibrant, and used to characterize the molecular weight distribution of polydisperse samples or the peak molecular weight of monodisperse, or approximately monodisperse, heparin fractions. The same technology can be adapted for use with other glycosaminoglycans.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25325948     DOI: 10.1007/978-1-4939-1714-3_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Modernization of Enoxaparin Molecular Weight Determination Using Homogeneous Standards.

Authors:  Katelyn M Arnold; Stephen J Capuzzi; Yongmei Xu; Eugene N Muratov; Kevin Carrick; Anita Y Szajek; Alexander Tropsha; Jian Liu
Journal:  Pharmaceuticals (Basel)       Date:  2017-07-22

2.  Assessment of Heparanase-Mediated Angiogenesis Using Microvascular Endothelial Cells: Identification of λ-Carrageenan Derivative as a Potent Anti Angiogenic Agent.

Authors:  Nicolas Poupard; Pamela Badarou; Fabienne Fasani; Hugo Groult; Nicolas Bridiau; Frédéric Sannier; Stéphanie Bordenave-Juchereau; Claudine Kieda; Jean-Marie Piot; Catherine Grillon; Ingrid Fruitier-Arnaudin; Thierry Maugard
Journal:  Mar Drugs       Date:  2017-05-09       Impact factor: 5.118

Review 3.  General Considerations for Diversifying Heparin Drug Products by Improving the Current Heparin Manufacturing Process and Reintroducing Bovine Sourced Heparin to the US Market.

Authors:  Ali Al-Hakim
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

4.  Precipitation and Neutralization of Heparin from Different Sources by Protamine Sulfate.

Authors:  John Hogwood; Barbara Mulloy; Elaine Gray
Journal:  Pharmaceuticals (Basel)       Date:  2017-07-02

5.  By-Products of Heparin Production Provide a Diverse Source of Heparin-like and Heparan Sulfate Glycosaminoglycans.

Authors:  Sarah L Taylor; John Hogwood; Wei Guo; Edwin A Yates; Jeremy E Turnbull
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

6.  Production of Active Poly- and Oligosaccharidic Fractions from Ulva sp. by Combining Enzyme-Assisted Extraction (EAE) and Depolymerization.

Authors:  Mathilde Fournière; Thomas Latire; Marie Lang; Nolwenn Terme; Nathalie Bourgougnon; Gilles Bedoux
Journal:  Metabolites       Date:  2019-09-12

7.  Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.

Authors:  Julia A Tree; Jeremy E Turnbull; Karen R Buttigieg; Michael J Elmore; Naomi Coombes; John Hogwood; Courtney J Mycroft-West; Marcelo A Lima; Mark A Skidmore; Richard Karlsson; Yen-Hsi Chen; Zhang Yang; Cosma Mirella Spalluto; Karl J Staples; Edwin A Yates; Elaine Gray; Dave Singh; Tom Wilkinson; Clive P Page; Miles W Carroll
Journal:  Br J Pharmacol       Date:  2020-12-14       Impact factor: 9.473

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.